Accelerating clinical development of a live attenuated vaccine against Salmonella Paratyphi A (VASP): study protocol for an observer-participant-blind randomised control trial of a novel oral vaccine using a human challenge model of Salmonella Paratyphi A infection in healthy adult volunteers.
BMJ Open
; 13(5): e068966, 2023 05 24.
Article
in En
| MEDLINE
| ID: mdl-37225278
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Salmonella paratyphi A
/
Cardiovascular Diseases
Type of study:
Clinical_trials
/
Guideline
/
Prognostic_studies
Aspects:
Ethics
Limits:
Adult
/
Humans
Language:
En
Journal:
BMJ Open
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: